| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anesthesiology | 15 | 2022 | 157 | 3.730 |
Why?
|
| Perioperative Care | 12 | 2022 | 161 | 2.630 |
Why?
|
| Ambulatory Surgical Procedures | 16 | 2014 | 74 | 2.290 |
Why?
|
| Airway Management | 5 | 2022 | 46 | 2.240 |
Why?
|
| Anesthesiologists | 3 | 2022 | 29 | 2.180 |
Why?
|
| Analgesics | 8 | 2022 | 119 | 2.030 |
Why?
|
| Societies, Medical | 6 | 2022 | 572 | 2.010 |
Why?
|
| Anesthesia | 9 | 2022 | 164 | 1.710 |
Why?
|
| Intubation, Intratracheal | 4 | 2022 | 144 | 1.480 |
Why?
|
| Pain, Postoperative | 9 | 2022 | 240 | 1.480 |
Why?
|
| Catheterization, Central Venous | 4 | 2020 | 116 | 1.400 |
Why?
|
| Practice Guidelines as Topic | 6 | 2022 | 1036 | 1.390 |
Why?
|
| Psychomotor Performance | 25 | 1997 | 492 | 1.290 |
Why?
|
| Anesthesia, Local | 4 | 2015 | 27 | 1.220 |
Why?
|
| Propofol | 17 | 2013 | 89 | 1.200 |
Why?
|
| Anesthetics, Inhalation | 9 | 2018 | 95 | 1.020 |
Why?
|
| Delivery of Health Care, Integrated | 2 | 2015 | 57 | 1.000 |
Why?
|
| Anesthetics, Local | 2 | 2015 | 76 | 0.990 |
Why?
|
| Advisory Committees | 5 | 2020 | 90 | 0.970 |
Why?
|
| Nitrous Oxide | 15 | 1997 | 107 | 0.970 |
Why?
|
| Narcotics | 3 | 2022 | 69 | 0.890 |
Why?
|
| Patient-Centered Care | 2 | 2015 | 203 | 0.890 |
Why?
|
| Research Report | 3 | 2020 | 44 | 0.740 |
Why?
|
| Internship and Residency | 3 | 2021 | 1004 | 0.730 |
Why?
|
| Affect | 14 | 1997 | 386 | 0.730 |
Why?
|
| Evidence-Based Medicine | 5 | 2021 | 429 | 0.690 |
Why?
|
| Anesthetics | 4 | 2021 | 48 | 0.670 |
Why?
|
| Humans | 97 | 2022 | 86643 | 0.610 |
Why?
|
| Isoflurane | 6 | 2018 | 64 | 0.610 |
Why?
|
| Anesthesia Recovery Period | 10 | 2018 | 56 | 0.600 |
Why?
|
| Critical Care | 2 | 2019 | 370 | 0.570 |
Why?
|
| Pain Measurement | 8 | 2013 | 321 | 0.560 |
Why?
|
| Pharmacogenomic Testing | 3 | 2021 | 97 | 0.520 |
Why?
|
| Analgesics, Opioid | 5 | 2004 | 413 | 0.520 |
Why?
|
| Pharmacogenetics | 5 | 2022 | 434 | 0.510 |
Why?
|
| Postoperative Care | 2 | 2013 | 221 | 0.510 |
Why?
|
| Fentanyl | 6 | 1996 | 65 | 0.500 |
Why?
|
| Operating Rooms | 4 | 2019 | 126 | 0.500 |
Why?
|
| Midazolam | 6 | 1996 | 48 | 0.490 |
Why?
|
| Hypothermia | 2 | 2013 | 26 | 0.470 |
Why?
|
| Patient Satisfaction | 4 | 2013 | 455 | 0.470 |
Why?
|
| Anesthesia, Intravenous | 9 | 1996 | 35 | 0.460 |
Why?
|
| Body Temperature Regulation | 1 | 2013 | 56 | 0.460 |
Why?
|
| Ambulatory Care Facilities | 1 | 2014 | 102 | 0.450 |
Why?
|
| Fires | 1 | 2013 | 17 | 0.450 |
Why?
|
| Emergency Medical Services | 1 | 2015 | 209 | 0.440 |
Why?
|
| Anesthetics, Intravenous | 4 | 2013 | 41 | 0.440 |
Why?
|
| Hypnotics and Sedatives | 4 | 2013 | 125 | 0.440 |
Why?
|
| Fever | 1 | 2013 | 125 | 0.430 |
Why?
|
| United States | 12 | 2022 | 6672 | 0.410 |
Why?
|
| Patient Compliance | 1 | 2013 | 227 | 0.410 |
Why?
|
| Surgical Procedures, Operative | 1 | 2013 | 182 | 0.400 |
Why?
|
| Motivation | 3 | 2021 | 287 | 0.400 |
Why?
|
| Physicians | 2 | 2015 | 673 | 0.400 |
Why?
|
| Cognition | 8 | 1997 | 570 | 0.380 |
Why?
|
| Respiratory Aspiration | 1 | 2010 | 5 | 0.370 |
Why?
|
| Cold Temperature | 7 | 1997 | 157 | 0.360 |
Why?
|
| Clinical Competence | 1 | 2015 | 751 | 0.360 |
Why?
|
| Surveys and Questionnaires | 6 | 2013 | 2501 | 0.360 |
Why?
|
| Double-Blind Method | 23 | 2018 | 1823 | 0.350 |
Why?
|
| Patient Selection | 1 | 2013 | 685 | 0.340 |
Why?
|
| Hallux Valgus | 1 | 2008 | 3 | 0.340 |
Why?
|
| Adult | 54 | 2018 | 25648 | 0.340 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2008 | 33 | 0.340 |
Why?
|
| Recovery Room | 2 | 1998 | 2 | 0.340 |
Why?
|
| Isoxazoles | 1 | 2008 | 77 | 0.330 |
Why?
|
| Ethers | 3 | 1997 | 14 | 0.320 |
Why?
|
| Risk Assessment | 3 | 2021 | 2261 | 0.310 |
Why?
|
| Methyl Ethers | 3 | 1997 | 33 | 0.310 |
Why?
|
| Cross-Over Studies | 12 | 2018 | 399 | 0.300 |
Why?
|
| Anesthesia, Inhalation | 5 | 1996 | 36 | 0.290 |
Why?
|
| Anesthesia, General | 2 | 2001 | 114 | 0.280 |
Why?
|
| Ethanol | 5 | 1995 | 249 | 0.280 |
Why?
|
| Opioid-Related Disorders | 2 | 2019 | 161 | 0.270 |
Why?
|
| Prospective Studies | 15 | 2022 | 4213 | 0.270 |
Why?
|
| Pain Management | 2 | 2019 | 127 | 0.270 |
Why?
|
| Postanesthesia Nursing | 2 | 2002 | 2 | 0.260 |
Why?
|
| Health Personnel | 2 | 2020 | 202 | 0.260 |
Why?
|
| Academic Medical Centers | 2 | 2005 | 379 | 0.260 |
Why?
|
| Physician Incentive Plans | 1 | 2005 | 21 | 0.260 |
Why?
|
| Male | 50 | 2022 | 40965 | 0.260 |
Why?
|
| Patient Readmission | 2 | 2019 | 329 | 0.250 |
Why?
|
| Female | 46 | 2022 | 44532 | 0.230 |
Why?
|
| Neuromuscular Blocking Agents | 2 | 2013 | 29 | 0.220 |
Why?
|
| Infusions, Intravenous | 4 | 2010 | 429 | 0.220 |
Why?
|
| Randomized Controlled Trials as Topic | 6 | 2019 | 865 | 0.210 |
Why?
|
| Thorax | 1 | 2022 | 75 | 0.210 |
Why?
|
| Electroencephalography | 2 | 2010 | 709 | 0.210 |
Why?
|
| Tramadol | 1 | 2022 | 14 | 0.210 |
Why?
|
| Respiratory System | 1 | 2022 | 116 | 0.210 |
Why?
|
| Consensus | 2 | 2013 | 335 | 0.200 |
Why?
|
| Pharmacogenomic Variants | 1 | 2021 | 41 | 0.200 |
Why?
|
| Immersion | 3 | 1997 | 21 | 0.190 |
Why?
|
| Awareness | 1 | 2001 | 93 | 0.190 |
Why?
|
| Substance-Related Disorders | 2 | 1995 | 394 | 0.190 |
Why?
|
| Veins | 1 | 2020 | 94 | 0.180 |
Why?
|
| Butorphanol | 2 | 1997 | 9 | 0.180 |
Why?
|
| Decision Support Techniques | 1 | 2021 | 160 | 0.180 |
Why?
|
| Drug Tolerance | 2 | 1996 | 63 | 0.180 |
Why?
|
| Dose-Response Relationship, Drug | 9 | 2011 | 1961 | 0.180 |
Why?
|
| Urination | 2 | 2013 | 37 | 0.170 |
Why?
|
| Injections, Intravenous | 8 | 1996 | 244 | 0.170 |
Why?
|
| Citrates | 1 | 2018 | 28 | 0.170 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2019 | 103 | 0.160 |
Why?
|
| Length of Stay | 2 | 2018 | 702 | 0.160 |
Why?
|
| Respiratory Insufficiency | 1 | 2020 | 150 | 0.160 |
Why?
|
| Pain Threshold | 2 | 1996 | 58 | 0.160 |
Why?
|
| Arousal | 2 | 1996 | 170 | 0.160 |
Why?
|
| Succinylcholine | 3 | 2022 | 14 | 0.160 |
Why?
|
| Mental Recall | 3 | 1995 | 159 | 0.160 |
Why?
|
| Caffeine | 1 | 2018 | 81 | 0.160 |
Why?
|
| Middle Aged | 18 | 2018 | 25028 | 0.150 |
Why?
|
| Inpatients | 1 | 2020 | 297 | 0.150 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2019 | 199 | 0.150 |
Why?
|
| Anti-Anxiety Agents | 1 | 1996 | 23 | 0.150 |
Why?
|
| Monitoring, Physiologic | 2 | 2013 | 268 | 0.140 |
Why?
|
| Wakefulness | 1 | 1996 | 134 | 0.140 |
Why?
|
| Central Nervous System Stimulants | 1 | 2018 | 216 | 0.140 |
Why?
|
| Time Factors | 9 | 2018 | 5210 | 0.140 |
Why?
|
| Neuromuscular Nondepolarizing Agents | 1 | 1995 | 14 | 0.130 |
Why?
|
| Lidocaine | 2 | 1985 | 63 | 0.130 |
Why?
|
| Nausea | 4 | 2011 | 175 | 0.130 |
Why?
|
| Respiration | 3 | 1985 | 262 | 0.130 |
Why?
|
| Isoquinolines | 1 | 1995 | 72 | 0.130 |
Why?
|
| Patient Care | 1 | 2015 | 100 | 0.120 |
Why?
|
| Poisoning | 1 | 2014 | 42 | 0.120 |
Why?
|
| Analgesia | 2 | 2013 | 57 | 0.120 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 1996 | 243 | 0.120 |
Why?
|
| Data Collection | 3 | 2005 | 372 | 0.120 |
Why?
|
| Thiopental | 4 | 1997 | 15 | 0.120 |
Why?
|
| Deep Sedation | 1 | 2013 | 15 | 0.120 |
Why?
|
| Memory | 5 | 1997 | 225 | 0.120 |
Why?
|
| Thalamic Nuclei | 1 | 2013 | 32 | 0.120 |
Why?
|
| Aged | 13 | 2018 | 18415 | 0.110 |
Why?
|
| Patients | 1 | 2014 | 100 | 0.110 |
Why?
|
| Shivering | 1 | 2013 | 4 | 0.110 |
Why?
|
| Postoperative Nausea and Vomiting | 1 | 2013 | 17 | 0.110 |
Why?
|
| Safety | 2 | 2013 | 152 | 0.110 |
Why?
|
| Mental Processes | 1 | 2013 | 31 | 0.110 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2013 | 36 | 0.110 |
Why?
|
| Fiber Optic Technology | 1 | 2013 | 35 | 0.110 |
Why?
|
| Laryngoscopy | 1 | 2013 | 44 | 0.110 |
Why?
|
| Outpatients | 1 | 2013 | 94 | 0.110 |
Why?
|
| Evaluation Studies as Topic | 2 | 2012 | 274 | 0.110 |
Why?
|
| Respiratory Function Tests | 1 | 2013 | 136 | 0.110 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2013 | 60 | 0.110 |
Why?
|
| Neurologic Examination | 1 | 2013 | 118 | 0.110 |
Why?
|
| Substance Abuse, Intravenous | 1 | 1993 | 54 | 0.110 |
Why?
|
| Adolescent | 10 | 2013 | 8981 | 0.110 |
Why?
|
| Vomiting | 4 | 2004 | 193 | 0.110 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2015 | 3362 | 0.110 |
Why?
|
| Risk Factors | 3 | 2021 | 5417 | 0.110 |
Why?
|
| Health Care Surveys | 1 | 2013 | 278 | 0.100 |
Why?
|
| Physical Examination | 1 | 2013 | 149 | 0.100 |
Why?
|
| Patient Safety | 1 | 2014 | 212 | 0.100 |
Why?
|
| Trachea | 1 | 2013 | 293 | 0.100 |
Why?
|
| Arthralgia | 1 | 2011 | 36 | 0.100 |
Why?
|
| Pain | 3 | 2022 | 391 | 0.100 |
Why?
|
| Bupivacaine | 1 | 2011 | 45 | 0.100 |
Why?
|
| Anxiety | 1 | 2013 | 287 | 0.100 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2014 | 219 | 0.100 |
Why?
|
| Nerve Block | 1 | 2011 | 51 | 0.100 |
Why?
|
| Dexmedetomidine | 1 | 2010 | 11 | 0.090 |
Why?
|
| Esophageal Sphincter, Lower | 1 | 2010 | 32 | 0.090 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2011 | 111 | 0.090 |
Why?
|
| Conscious Sedation | 1 | 2010 | 64 | 0.090 |
Why?
|
| Vecuronium Bromide | 1 | 1989 | 3 | 0.090 |
Why?
|
| Product Surveillance, Postmarketing | 6 | 1993 | 37 | 0.090 |
Why?
|
| Ondansetron | 3 | 1993 | 21 | 0.080 |
Why?
|
| Administration, Inhalation | 4 | 1997 | 188 | 0.080 |
Why?
|
| Muscular Diseases | 1 | 1989 | 63 | 0.080 |
Why?
|
| Carbon Dioxide | 3 | 1985 | 188 | 0.080 |
Why?
|
| Databases, Factual | 3 | 2020 | 814 | 0.080 |
Why?
|
| Patient Discharge | 2 | 2003 | 300 | 0.080 |
Why?
|
| Drug Administration Schedule | 1 | 2008 | 916 | 0.070 |
Why?
|
| Prognosis | 1 | 2014 | 3679 | 0.070 |
Why?
|
| Methohexital | 1 | 1985 | 2 | 0.070 |
Why?
|
| Animals | 2 | 2015 | 26582 | 0.070 |
Why?
|
| Etomidate | 1 | 1985 | 11 | 0.070 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2005 | 23 | 0.070 |
Why?
|
| Blood Proteins | 1 | 1985 | 144 | 0.060 |
Why?
|
| Disposable Equipment | 1 | 1985 | 18 | 0.060 |
Why?
|
| Efficiency | 1 | 2005 | 40 | 0.060 |
Why?
|
| Imidazoles | 1 | 1985 | 162 | 0.060 |
Why?
|
| Cholecystectomy, Laparoscopic | 1 | 2004 | 50 | 0.060 |
Why?
|
| Hemodynamics | 3 | 1996 | 710 | 0.060 |
Why?
|
| Anesthesia Department, Hospital | 1 | 2003 | 8 | 0.060 |
Why?
|
| Blood Pressure | 4 | 1996 | 1143 | 0.060 |
Why?
|
| Efficiency, Organizational | 1 | 2003 | 58 | 0.060 |
Why?
|
| Follow-Up Studies | 2 | 2002 | 3640 | 0.050 |
Why?
|
| Drug Interactions | 4 | 1996 | 248 | 0.050 |
Why?
|
| Hospital Units | 1 | 2002 | 30 | 0.050 |
Why?
|
| Omeprazole | 1 | 2022 | 11 | 0.050 |
Why?
|
| Hydralazine | 1 | 2022 | 20 | 0.050 |
Why?
|
| Random Allocation | 3 | 1993 | 332 | 0.050 |
Why?
|
| Laparoscopy | 1 | 1989 | 754 | 0.050 |
Why?
|
| Oxycodone | 1 | 2022 | 35 | 0.050 |
Why?
|
| Young Adult | 1 | 2013 | 5976 | 0.050 |
Why?
|
| Memory, Short-Term | 2 | 1995 | 220 | 0.050 |
Why?
|
| Anesthesia, Obstetrical | 2 | 1996 | 25 | 0.050 |
Why?
|
| Oxygen | 2 | 1996 | 726 | 0.050 |
Why?
|
| Postoperative Complications | 3 | 2020 | 2207 | 0.050 |
Why?
|
| Costs and Cost Analysis | 1 | 2001 | 153 | 0.050 |
Why?
|
| Nurse Anesthetists | 1 | 2020 | 4 | 0.050 |
Why?
|
| Patient Education as Topic | 1 | 2003 | 351 | 0.050 |
Why?
|
| Anesthesia, Endotracheal | 2 | 1990 | 6 | 0.050 |
Why?
|
| Central Venous Catheters | 1 | 2020 | 23 | 0.050 |
Why?
|
| Euphoria | 2 | 1996 | 43 | 0.040 |
Why?
|
| Hypoxia | 1 | 1984 | 641 | 0.040 |
Why?
|
| Aged, 80 and over | 7 | 2011 | 6509 | 0.040 |
Why?
|
| Progressive Patient Care | 1 | 1998 | 2 | 0.040 |
Why?
|
| Clinical Decision-Making | 1 | 2021 | 257 | 0.040 |
Why?
|
| Point-of-Care Systems | 1 | 2019 | 141 | 0.040 |
Why?
|
| Placebos | 2 | 1996 | 218 | 0.040 |
Why?
|
| Pregnancy | 3 | 1996 | 2894 | 0.040 |
Why?
|
| Pulmonary Artery | 1 | 2020 | 306 | 0.040 |
Why?
|
| Hospitalization | 1 | 2003 | 849 | 0.040 |
Why?
|
| Child | 3 | 2020 | 6927 | 0.040 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 1997 | 46 | 0.040 |
Why?
|
| Hospital Costs | 1 | 2018 | 105 | 0.040 |
Why?
|
| Cholinesterases | 2 | 1995 | 17 | 0.040 |
Why?
|
| Infusion Pumps | 1 | 1996 | 25 | 0.040 |
Why?
|
| Central Nervous System Depressants | 1 | 1997 | 45 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2021 | 1673 | 0.040 |
Why?
|
| Alcohol Drinking | 2 | 1997 | 267 | 0.040 |
Why?
|
| Miosis | 1 | 1996 | 10 | 0.040 |
Why?
|
| Codeine | 1 | 1996 | 12 | 0.040 |
Why?
|
| Medicare | 1 | 2020 | 410 | 0.040 |
Why?
|
| Morphine | 1 | 1997 | 130 | 0.040 |
Why?
|
| Muscle Relaxation | 1 | 1996 | 18 | 0.030 |
Why?
|
| Motor Skills | 1 | 1996 | 71 | 0.030 |
Why?
|
| Clinical Trials, Phase IV as Topic | 1 | 1995 | 2 | 0.030 |
Why?
|
| Psychomotor Disorders | 1 | 1996 | 20 | 0.030 |
Why?
|
| Administration, Intranasal | 1 | 1996 | 136 | 0.030 |
Why?
|
| South America | 1 | 1995 | 29 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2008 | 7993 | 0.030 |
Why?
|
| Acetaminophen | 1 | 1996 | 54 | 0.030 |
Why?
|
| Flumazenil | 1 | 1995 | 8 | 0.030 |
Why?
|
| Surgeons | 1 | 2020 | 238 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 1996 | 153 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2020 | 1805 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2020 | 8489 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 1998 | 454 | 0.030 |
Why?
|
| Regional Blood Flow | 1 | 1996 | 197 | 0.030 |
Why?
|
| Japan | 1 | 1995 | 307 | 0.030 |
Why?
|
| Genetic Testing | 1 | 2019 | 535 | 0.030 |
Why?
|
| Precision Medicine | 1 | 2019 | 395 | 0.030 |
Why?
|
| Europe | 1 | 1995 | 309 | 0.030 |
Why?
|
| Central Nervous System | 1 | 1996 | 151 | 0.030 |
Why?
|
| Hydrolysis | 1 | 1995 | 141 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 2019 | 636 | 0.030 |
Why?
|
| Reference Standards | 1 | 1995 | 159 | 0.030 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2019 | 582 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 1995 | 227 | 0.030 |
Why?
|
| Cognition Disorders | 1 | 1996 | 236 | 0.030 |
Why?
|
| Bradycardia | 1 | 1993 | 39 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 1996 | 894 | 0.030 |
Why?
|
| Administration, Oral | 1 | 1995 | 684 | 0.030 |
Why?
|
| Hypotension | 1 | 1993 | 70 | 0.030 |
Why?
|
| Tobacco Smoke Pollution | 1 | 1993 | 23 | 0.030 |
Why?
|
| Heart | 1 | 1996 | 539 | 0.030 |
Why?
|
| Pulse | 1 | 1992 | 18 | 0.030 |
Why?
|
| Choice Behavior | 1 | 1993 | 160 | 0.030 |
Why?
|
| Attention | 1 | 1996 | 388 | 0.030 |
Why?
|
| Medical History Taking | 1 | 1992 | 80 | 0.030 |
Why?
|
| Sleep | 1 | 1996 | 444 | 0.030 |
Why?
|
| Premedication | 1 | 2011 | 54 | 0.030 |
Why?
|
| Health Status Indicators | 1 | 1992 | 105 | 0.030 |
Why?
|
| Nicotine | 1 | 1993 | 194 | 0.020 |
Why?
|
| Osteoarthritis, Knee | 1 | 2011 | 63 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 1993 | 502 | 0.020 |
Why?
|
| Postoperative Period | 2 | 1991 | 303 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 2271 | 0.020 |
Why?
|
| Enflurane | 1 | 1989 | 2 | 0.020 |
Why?
|
| Lung | 1 | 1996 | 1170 | 0.020 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 1992 | 332 | 0.020 |
Why?
|
| Drug Evaluation | 1 | 1989 | 141 | 0.020 |
Why?
|
| Smoking | 1 | 1993 | 609 | 0.020 |
Why?
|
| Hot Temperature | 1 | 1987 | 206 | 0.020 |
Why?
|
| Chymopapain | 1 | 1985 | 6 | 0.020 |
Why?
|
| Kinetics | 2 | 1986 | 1513 | 0.020 |
Why?
|
| Anaphylaxis | 1 | 1985 | 33 | 0.020 |
Why?
|
| Breath Tests | 1 | 1985 | 55 | 0.020 |
Why?
|
| Infusions, Parenteral | 1 | 1984 | 50 | 0.020 |
Why?
|
| Physostigmine | 1 | 1984 | 19 | 0.020 |
Why?
|
| Postpartum Period | 1 | 1986 | 135 | 0.020 |
Why?
|
| Diazepam | 1 | 1984 | 28 | 0.020 |
Why?
|
| Water | 2 | 1997 | 277 | 0.020 |
Why?
|
| Equipment Failure | 1 | 1985 | 119 | 0.020 |
Why?
|
| Uncompensated Care | 1 | 2003 | 2 | 0.010 |
Why?
|
| Health Facility Size | 1 | 2003 | 9 | 0.010 |
Why?
|
| Documentation | 1 | 2003 | 98 | 0.010 |
Why?
|
| Heart Rate | 1 | 1984 | 492 | 0.010 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2003 | 93 | 0.010 |
Why?
|
| Community Health Centers | 1 | 2003 | 113 | 0.010 |
Why?
|
| Protein Binding | 1 | 1985 | 1456 | 0.010 |
Why?
|
| Pressure | 1 | 1995 | 165 | 0.010 |
Why?
|
| Temperature | 1 | 1995 | 396 | 0.010 |
Why?
|
| Flicker Fusion | 1 | 1992 | 5 | 0.010 |
Why?
|
| Attitude to Computers | 1 | 1992 | 12 | 0.010 |
Why?
|
| Preventive Medicine | 1 | 1992 | 17 | 0.010 |
Why?
|
| Headache | 1 | 1992 | 73 | 0.010 |
Why?
|
| Computers | 1 | 1992 | 112 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 1993 | 297 | 0.010 |
Why?
|
| Interviews as Topic | 1 | 1992 | 319 | 0.010 |
Why?
|
| Remission Induction | 1 | 1992 | 722 | 0.010 |
Why?
|
| Smoking Cessation | 1 | 1993 | 230 | 0.010 |
Why?
|
| Learning | 1 | 1993 | 280 | 0.010 |
Why?
|
| Health Status | 1 | 1992 | 360 | 0.010 |
Why?
|
| Preoperative Care | 1 | 1992 | 397 | 0.010 |
Why?
|
| Humidity | 1 | 1987 | 89 | 0.000 |
Why?
|
| Body Temperature | 1 | 1987 | 124 | 0.000 |
Why?
|
| Pregnancy Trimester, Third | 1 | 1986 | 70 | 0.000 |
Why?
|
| Contraceptives, Oral | 1 | 1986 | 46 | 0.000 |
Why?
|
| Mathematics | 1 | 1986 | 190 | 0.000 |
Why?
|
| Histamine H1 Antagonists | 1 | 1985 | 40 | 0.000 |
Why?
|
| Sympathetic Nervous System | 1 | 1985 | 104 | 0.000 |
Why?
|
| Glycopyrrolate | 1 | 1984 | 4 | 0.000 |
Why?
|